Making innovation operational
Mark Hronec is a biopharma operations and quality leader who partners with emerging and established companies to modernize operations, strengthen execution, and scale from discovery through commercialization. With a foundation in biochemistry and an MBA from Carnegie Mellon, he blends technical mastery with strategic insight to guide organizations through complex transitions, from inspection readiness to enterprise operating model design and execution.
His experience spans leading global process redesigns, operational transformations, and workforce strategies for clients including Bristol Myers Squibb, Jazz Pharmaceuticals, and Abivax.
A former scientist turned senior consultant, Mark brings both empathy and precision to his work, helping leaders make decisions that are scientifically sound, operationally feasible, and commercially smart. His commitment is simple yet profound: advancing the systems that bring life-saving medicines to patients faster.
MBA
Carnegie Mellon University, Tepper School of Business
M.S., Biochemistry
Brandeis University
B.S., Biology & Biochemistry
Brandeis University
Strategic Workforce Planning
Human Capital Institute (HCI)
Business Process Management
APQC
Expertise:
- Development Acceleration
- Strategic Workforce Planning & Resource Management
- Change Management
- Portfolio, Program, & Project Management
- Operational Excellence
- Business Process Management
What Motivates Me:
I'm driven to help companies transform discovery into delivery, so life-changing medicines reach patients when time matters most.
